Note 15 - Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Three Months Ended
	March 31, 2023
	Options			Wtd. Avg. Exercise Price
Outstanding as of beginning of year		456,293		$	2.16
Exercised		(80,938	)		2.06
Outstanding as of March 31, 2023		375,355		$	2.18
Stock options exercisable as of March 31, 2023		375,355		$	2.18

Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

	Three Months Ended
	March 31, 2023
	Shares			Wtd. Avg. Grant Date Fair Value
Outstanding as of beginning of year		1,879,215		$	28.94
Granted		414,601			17.67
Vested		(346,184	)		27.51
Forfeited		(70,725	)		29.67
Non-vested as of March 31, 2023		1,876,907		$	26.69

	Three Months Ended
	March 31, 2023
	Shares			Wtd. Avg. Grant
Outstanding as of beginning of year		271,044		$	30.64
Granted		268,738			24.23
Vested		(30,616	)		51.65
Non-vested as of March 31, 2023		509,166		$	26.00

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Three Months Ended
	March 31,
(In thousands)	2023		2022
Cost of revenue	$	1,631	$	1,007
General and administrative costs		3,293		3,010
Sales and marketing costs		1,256		705
Research and development costs		1,183		677
Total	$	7,363	$	5,399